Massachusetts · Bill 2035 · 194th General Court
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
- Introduced Feb 27, 2025
- In committee Feb 27, 2025
- Failed
- Passed the House
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
By Mr. Lewis, a petition (accompanied by bill, Senate, No. 2035) of Jason M. Lewis and Rebecca L. Rausch for legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.
Every action
5 steps, oldest first, as the legislature records them.
- CommitteeReferred to the committee on Revenue · Joint Committee on Revenue
- HouseHouse concurred
- CommitteeHearing scheduled for 10/28/2025 from 01:00 PM-05:00 PM in B-2 · Joint Committee on Revenue
- SenateReporting date extended to Thursday June 25, 2026
- HouseAccompanied a study order, see H5596
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it, joined by 1 cosponsor: 1 Democrat.
-
Jason M. LewisD Primary sponsor · District Fifth Middlesex
All 1 cosponsor
From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.